Pharma Deutschland to Hold Seminar on New Drug Market Access

Pharma Deutschland e.V. is organizing a seminar on September 8, 2026, addressing the complexities of bringing innovative pharmaceuticals to the German market. The online event, titled "Market-Access II - What to Consider When Introducing Innovative Medicines to the German Market?", aims to guide industry professionals through regulatory hurdles.

The seminar will cover essential procedural steps within Germany's AMNOG process, which governs drug pricing and reimbursement. Participants will learn about the requirements of Health Technology Assessment (HTA) institutions and the considerations for key decision-makers, encouraging proactive planning during a drug's clinical development phase.

Attendees will gain insights into the framework for negotiations on reimbursement amounts and strategies for successful preparation and execution. The program combines theoretical knowledge with practical examples drawn from over a decade of experience with the AMNOG process in Germany. The goal is to help companies optimize the steps involved in bringing a medicinal product to market.

The event is scheduled to take place online from 09:30 to 15:30. Pharma Deutschland e.V. serves as a key association for the pharmaceutical industry in Germany.